|
Gufic BioSciences Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
3234.45 Cr.
|
P/BV
|
9.29
|
Book Value (Rs.)
|
34.72
|
|
52 Week High/Low (Rs.)
|
365/194
|
FV/ML
|
1/1
|
P/E(X)
|
40.58
|
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
7.95
|
Div Yield (%)
|
0.03
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 201.78 | 214.87 | 195.02 |
| Total Income From Operations | 201.78 | 214.87 | 195.02 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 72.92 | 95.29 | 80.38 |
| Purchase of Traded Goods | 12.00 | 15.66 | 16.06 |
| Increase/Decrease in Stocks | 10.41 | -1.84 | 0.39 |
| Employees Cost | 30.60 | 26.78 | 23.37 |
| Depreciation | 4.14 | 4.30 | 4.24 |
| Other Expenses | 39.38 | 39.62 | 38.99 |
| Total Expenses | 169.46 | 179.80 | 163.44 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 32.31 | 35.07 | 31.58 |
| Other Income | 0.42 | 0.33 | 0.54 |
| P/L Before Interest, Excpt. Items & Tax | 32.74 | 35.41 | 32.12 |
| Interest | 3.18 | 4.46 | 4.07 |
| P/L Before Exceptional Items & Tax | 29.56 | 30.95 | 28.05 |
| P/L Before Tax | 29.56 | 30.95 | 28.05 |
| Tax | 7.30 | 7.74 | 7.43 |
| P/L After Tax from Ordinary Activities | 22.26 | 23.21 | 20.62 |
| Net Profit/Loss For the Period | 22.26 | 23.21 | 20.62 |
| Net P/L After Minority Interest & Share Of Associates | 22.26 | 23.21 | 20.62 |
| | | | |
| Equity Share Capital | 10.03 | 9.69 | 9.69 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 2.23 | 2.39 | 2.13 |
| Diluted EPS (Rs.) | 2.23 | 2.39 | 2.13 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 2.23 | 2.39 | 2.13 |
| Diluted EPS (Rs.) | 2.23 | 2.39 | 0.00 |
| | | | |
| PBITOE Margin (%) | 16.01 | 16.32 | 16.19 |
| PBTE Margin (%) | 14.64 | 14.40 | 14.38 |
| PBT Margin (%) | 14.64 | 14.40 | 14.38 |
| PAT Margin (%) | 11.03 | 10.80 | 10.57 |
| PAT After MI And SOA Margin (%) | 11.03 | 10.80 | 10.57 |